Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral species

This work was partially supported by the DARPAINTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) program (DARPA-BAA-16-35), CDC Emerging Infectious Disease Research Core Funds, an appointment to the Research Participation Program at the Centers for Disease Control and Prevention (CDC) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC (K.A.D., S.E.R.), and by NIAID1R01AI151006 (T.E.S).

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2025-08-25
DOI
https://doi.org/10.1016/j.ebiom.2025.105897
Citations
1
Primary Topic
Virology and Viral Diseases
Type
article
Field-Weighted Citation Impact
1.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral species

Jessica R. Spengler, Sarah C. Genzer, Stephen R. Welch, Katherine Davies et al.
1 citations
EBioMedicine
Virology and Viral Diseases
1.35
article

Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral species

Jessica R. Spengler, Sarah C. Genzer, Stephen R. Welch, Katherine Davies, Florine E. M. Scholte, JoAnn D. Coleman-McCray, Christina F. Spiropoulou, Sergio E. Rodriguez, Jessica R. Harmon, Joel M. Montgomery, Teresa E. Sorvillo, Stuart T. Nichol
article en
1 citations

Abstract

This work was partially supported by the DARPAINTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) program (DARPA-BAA-16-35), CDC Emerging Infectious Disease Research Core Funds, an appointment to the Research Participation Program at the Centers for Disease Control and Prevention (CDC) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC (K.A.D., S.E.R.), and by NIAID1R01AI151006 (T.E.S).

EBioMedicineVol. 119
Centers for Disease Control and Prevention (US), National Center for Emerging and Zoonotic Infectious Diseases (US)
U.S. Department of Energy, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Centers for Disease Control and Prevention, Defense Advanced Research Projects Agency, Oak Ridge Institute for Science and Education, National Institute of Allergy and Infectious Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Defense Sciences Office, DARPA
Zero hunger
Openalex Percentile: Top 16%
Virology and Viral Diseases
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.